Fig. 1
From: ATG5 as biomarker for early detection of malignant mesothelioma
Distribution of biomarkers in the study groups. Serum levels of ATG5, HMGB1, miR-126, miR-222 and Mesothelin in healthy controls (Ctrl), asbestos-exposed subjects (Exp), pre-diagnostic samples, and malignant pleural mesothelioma (MPM) patients. Comparisons among groups were determined by one-way ANOVA with Tukey post hoc analysis. Differences with p < 0.05 are statistically significant